The U.S. Senate cleared the way for the 21st Century Cures Act, an omnibus healthcare spending and reform bill, by voting 85-13 to end debate this evening.
As a group of experimental gene therapies—potentially long-lasting, if not permanent treatments—for the blood disease hemophilia continue to creep through clinical testing, a few things have become clear. They’re helping patients produce meaningful amounts of the blood-clotting proteins they lack for... Read more »
Are your security measures good enough?
We’re not talking about the locks on your house. We’re talking about the security of your sensitive personal data—health records, bank account passwords, and more—and the cyber defenses protecting businesses’ computer systems, data, files, intellectual... Read more »
The Global Innovation Exchange, a joint effort of the University of Washington and China’s Tsinghua University, is establishing some new models for intellectual property as it begins training what backers hope will be a new generation of innovation leaders.
Graduate students... Read more »
Keep up with the latest news from Wisconsin’s innovation community, starting with these recent headlines:
A diabetes drug jointly marketed by Eli Lilly (NYSE: LLY) and German pharmaceutical company Boehringer Ingelheim has won FDA approval expanding its use to include reducing the risk of cardiovascular death in diabetes patients.
The FDA initially approved empagliflozin (Jardiance)... Read more »
[Updated, 12/5/16, see below] Earlier this year, Celgene passed on an exclusive option to buy Acetylon Pharmaceuticals. But surprisingly, the two companies have come up with a new deal instead. Celgene agreed Friday to acquire just a portion... Read more »
Propeller Health’s respiratory disease management platform—which combines sensor-equipped inhalers with software applications and analytics—will now also be able to pull in measurements of patients’ lung function, thanks to a partnership with Italy-based Medical International Research (MIR) announced on Thursday.
MIR has... Read more »
We’ve packed some extra stuffing into the roundup this week to account for some burnt turkey delivered by biopharma in the few days before Thanksgiving—starting with Eli Lilly’s failed gamble in Alzheimer’s disease.
Lilly wasn’t alone, however. Several companies, among them... Read more »
[Corrected 12/5/16, 9:35 am. Awards were made in 10 categories.] Connect, the San Diego nonprofit supporting local innovation and entrepreneurship, handed out its Most Innovative New Product Awards at a dinner last night in La Jolla—recognizing innovations that range... Read more »
Arrowhead Pharmaceuticals has terminated the employment of chief scientific officer David Lewis, effective later this month, the company said in a regulatory filing that was made public on Thursday.
San Antonio—A cybersecurity firm in San Antonio called Delta Risk, which has owners and board members who once held high-ranking federal government posts, has raised $3 million only a few months after acquiring a Philadelphia-based competitor, according to a regulatory... Read more »
The methods of honing the skills of sales people are getting more sophisticated, as companies turn to mobile technologies, data analytics, and even neuroscience to coax the best performance possible from their sales teams.
Investors see promise here: Qstream announced today... Read more »
San Diego-based AttackIQ, a cybersecurity startup providing a Web-based platform for assessing network defenses, has finally closed its Series A round of founding, after raising a total of $8.8 million over the past three years, according to co-founder and CEO Stephan... Read more »
After canceling three liver drug programs and slashing its staff, Arrowhead Pharmaceuticals has nothing left in clinical trials. But a separate partnership with another biotech company, Amgen, could signal where Arrowhead goes next.
The strategy shift became necessary after Arrowhead (NASDAQ:... Read more »
Founder and CEO, Lighter Capital
Founder, Launch Fishers and Launch Indiana
Executive Partner, Sofinnova Ventures
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute